Literature DB >> 27433841

β-Lactams against Tuberculosis--New Trick for an Old Dog?

Andreas H Diacon1, Lize van der Merwe2, Marinus Barnard2, Florian von Groote-Bidlingmaier2, Christoph Lange3, Alberto L García-Basteiro4, Esperança Sevene5, Lluís Ballell6, David Barros-Aguirre6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27433841     DOI： 10.1056/NEJMc1513236

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  41 in total

1.  Revisiting the β-Lactams for Tuberculosis Therapy with a Compound-Compound Synthetic Lethality Approach.

Authors:  Shiqi Xiao; Haidan Guo; Warren S Weiner; Clinton Maddox; Chunhong Mao; Hendra Gunosewoyo; Shaaretha Pelly; E Lucile White; Lynn Rasmussen; Frank J Schoenen; Jeffrey Aubé; William R Bishai; Shichun Lun
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

2.  Classification of drugs to treat multidrug-resistant tuberculosis (MDR-TB): evidence and perspectives.

Authors:  Adrian Rendon; Simon Tiberi; Anna Scardigli; Lia D'Ambrosio; Rosella Centis; Jose A Caminero; Giovanni Battista Migliori
Journal:  J Thorac Dis       Date:  2016-10       Impact factor: 2.895

Review 3.  Peptidoglycan in Mycobacteria: chemistry, biology and intervention.

Authors:  Tripti Raghavendra; Saniya Patil; Raju Mukherjee
Journal:  Glycoconj J       Date:  2018-09-19       Impact factor: 2.916

4.  Negative Impact of Carbapenem Methylation on the Reactivity of β-Lactams for Cysteine Acylation as Revealed by Quantum Calculations and Kinetic Analyses.

Authors:  Nicholus Bhattacharjee; Sébastien Triboulet; Michel Arthur; Catherine M Bougault; Vincent Dubée; Matthieu Fonvielle; Zainab Edoo; Jean-Emmanuel Hugonnet; Mélanie Ethève-Quelquejeu; Jean-Pierre Simorre; Martin J Field
Journal:  Antimicrob Agents Chemother       Date:  2019-03-27       Impact factor: 5.191

5.  Mutation in an Unannotated Protein Confers Carbapenem Resistance in Mycobacterium tuberculosis.

Authors:  Pankaj Kumar; Amit Kaushik; Drew T Bell; Varsha Chauhan; Fangfang Xia; Rick L Stevens; Gyanu Lamichhane
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

6.  Dual-Pharmacophore Pyrithione-Containing Cephalosporins Kill Both Replicating and Nonreplicating Mycobacterium tuberculosis.

Authors:  Landys Lopez Quezada; Kelin Li; Stacey L McDonald; Quyen Nguyen; Andrew J Perkowski; Cameron W Pharr; Ben Gold; Julia Roberts; Kathrine McAulay; Kohta Saito; Selin Somersan Karakaya; Prisca Elis Javidnia; Esther Porras de Francisco; Manuel Marin Amieva; Sara Palomo Dı Az; Alfonso Mendoza Losana; Matthew Zimmerman; Hsin-Pin Ho Liang; Jun Zhang; Veronique Dartois; Stéphanie Sans; Sophie Lagrange; Laurent Goullieux; Christine Roubert; Carl Nathan; Jeffrey Aubé
Journal:  ACS Infect Dis       Date:  2019-06-11       Impact factor: 5.084

Review 7.  Potential anti-TB investigational compounds and drugs with repurposing potential in TB therapy: a conspectus.

Authors:  Adetomiwa A Adeniji; Kirsten E Knoll; Du Toit Loots
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-05       Impact factor: 4.813

8.  Time Trends in Sputum Mycobacterial Load and Two-Day Bactericidal Activity of Isoniazid-Containing Antituberculosis Therapies.

Authors:  Veronique De Jager; Lize van der Merwe; Amour Venter; Peter R Donald; Andreas H Diacon
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

9.  Pharmacokinetic Modeling and Limited Sampling Strategies Based on Healthy Volunteers for Monitoring of Ertapenem in Patients with Multidrug-Resistant Tuberculosis.

Authors:  S P van Rijn; M A Zuur; R van Altena; O W Akkerman; J H Proost; W C M de Lange; H A M Kerstjens; D J Touw; T S van der Werf; J G W Kosterink; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

10.  In Silico Screen and Structural Analysis Identifies Bacterial Kinase Inhibitors which Act with β-Lactams To Inhibit Mycobacterial Growth.

Authors:  Nathan Wlodarchak; Nathan Teachout; Jeffrey Beczkiewicz; Rebecca Procknow; Adam J Schaenzer; Kenneth Satyshur; Martin Pavelka; William Zuercher; David Drewry; John-Demian Sauer; Rob Striker
Journal:  Mol Pharm       Date:  2018-10-18       Impact factor: 4.939
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.